Key Takeaways Merck's shares have lost 25.6% in the past six months compared with a decline of 11.7% for the industry. The Zacks Consensus Estimate for 2024 earnings declined from $7.82 to $7.72 per ...

CURE® spoke with a lung cancer treatment expert about study findings showing survival benefits with the addition of ...

Certain chronic conditions that affect the lungs, such as asthma and chronic obstructive pulmonary disease (COPD), can have ...

In September, amivantamab (Rybrevant; Johnson & Johnson) received its fourth treatment indication from the FDA to treat ...

A woman who was diagnosed with stage 4 lung cancer has revealed the biggest lie she was told about the disease, urging others ...

The new drug, Jazz Pharmaceuticals’ zanidatamab, has won an FDA accelerated approval for adults with previously treated ...

In the video, she said: "One of the biggest lies I was taught is, if you don't smoke cigarettes, you won't get lung cancer. Well, I am a non-smoker, and in November of 2023 I was diagnosed with stage ...

Genprex (GNPX) announced it has entered into an exclusive license agreement with the University of Michigan, granting Genprex a worldwide, ...

When Ed O. went to the ER for shortness of breath and trembling, he never imagined he’d receive a diagnosis of unresectable ...

She didn't smoke but got advanced lung cancer. Genetic testing opened the door to targeted therapies. South Carolina doesn't ...

The survival rate among those with lung cancer has improved by more than a quarter in the last five years, according to a new ...